Data from Antihistamine Drug Ebastine Inhibits Cancer Growth by Targeting Polycomb Group Protein EZH2
Qiaqia Li(Northwestern University), Qi Cao(Northwestern University), Kaifu Chen(Boston Children's Hospital), Jenny C. Chang(Universität Hamburg), Xiongbing Zu(Central South University), Akash Patnaik(Johannes Gutenberg University Mainz), Chao Li(Northwestern University), Wei Qian, Rui Wang(Shanghai Medical College of Fudan University), Yan Lin(Chinese Academy of Medical Sciences & Peking Union Medical College), Guangyu Wang(Tongji University), Lili Zhang(Boston Children's Hospital), Sen Zhu, Yi Yang(National Yang Ming Chiao Tung University), Jung-Sun Kim(Oregon Health & Science University), Yongyong Yang, Qipeng Liu(First Affiliated Hospital of Henan University of Science and Technology), Weihua Jiang, Dongyu Zhao, Anthony J. Kozielski(Houston Methodist), Longxiang Wu(Northwestern University), Qingshu Meng, Kilia Y. Liu
Cited by 0
Related Papers
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a<i>BRCA1</i>or<i>BRCA2</i>Gene Alteration
|Journal of Clinical Oncology|2020|676
Pan-cancer image-based detection of clinically actionable genetic alterations
|Nature Cancer|2020|630
Mortality in vegetarians and nonvegetarians: detailed findings from a collaborative analysis of 5 prospective studies
|American Journal of Clinical Nutrition|1999|488